Johnson & Johnson Common Stock Dividends Paid 2010-2025 | JNJ
Johnson & Johnson annual/quarterly common stock dividends paid history and growth rate from 2010 to 2025. Common stock dividends paid can be defined as the cash outflow for dividends paid on a company's common stock
- Johnson & Johnson common stock dividends paid for the quarter ending March 31, 2025 were $-2.989B, a 4.18% increase year-over-year.
- Johnson & Johnson common stock dividends paid for the twelve months ending March 31, 2025 were $-29.505B, a 0.25% decline year-over-year.
- Johnson & Johnson annual common stock dividends paid for 2024 were $-11.823B, a 0.45% increase from 2023.
- Johnson & Johnson annual common stock dividends paid for 2023 were $-11.77B, a 0.75% increase from 2022.
- Johnson & Johnson annual common stock dividends paid for 2022 were $-11.682B, a 5.89% increase from 2021.
Johnson & Johnson Annual Common Stock Dividends Paid
(Millions of US $) |
| 2024 |
$-11,823 |
| 2023 |
$-11,770 |
| 2022 |
$-11,682 |
| 2021 |
$-11,032 |
| 2020 |
$-10,481 |
| 2019 |
$-9,917 |
| 2018 |
$-9,494 |
| 2017 |
$-8,943 |
| 2016 |
$-8,621 |
| 2015 |
$-8,173 |
| 2014 |
$-7,768 |
| 2013 |
$-7,286 |
| 2012 |
$-6,614 |
| 2011 |
$-6,156 |
| 2010 |
$-5,804 |
| 2009 |
$-5,327 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$360.406B |
$88.821B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
